427.29MMarket Cap
LossP/E TTM
IRD Balance Sheet
You can check out the annual or quarterly balance sheets of Opus Genetics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing IRD stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Opus Genetics Inc Have?
In its most recent quarterly, Opus Genetics Inc had 88.81M in cash and cash equivalents.
How Much Are Opus Genetics Inc's Total Liabilities?
Opus Genetics Inc reported 34.90M in total liabilities as of the latest reported quarter, including 7.78M in current liabilities and 27.11M in non-current liabilities.
What Are Opus Genetics Inc's Total Assets?
As of the latest reported quarter, Opus Genetics Inc's total assets were 50.24M, consisting of 50.04M in current assets and 199.00K in non-current assets.
How Much Shareholders' Equity Does Opus Genetics Inc Have?
Opus Genetics Inc reported 15.35M in total shareholders' equity as of the latest reported quarter.